Clinical Trials Directory

Trials / Completed

CompletedNCT03207698

PRF+1% MF for Class II Mandibular Furcation Defects

Evaluation of Adjunctive Effect of 1% Metformin To Platelet Rich Fibrin For Mandibular Class II Furcation Defects: A Randomized Controlled Clinical Trial

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
75 (actual)
Sponsor
Government Dental College and Research Institute, Bangalore · Academic / Other
Sex
All
Age
30 Years – 50 Years
Healthy volunteers
Accepted

Summary

The aim of the present trial is to evaluate the efficacy of PRF with 1% MF in treatment of mandibular class II furcation defects and its comparison to PRF and access therapy alone.

Detailed description

Background: For improving efficacy and outcomes of regenerative therapy for furcation defects, various materials has been investigated in addition to access therapy. Platelet-rich fibrin (PRF) having concentrated growth factors and cytokines and Metformin (MF), an efficacious member of biguanide group are known to enhance periodontal regeneration. The aim of the present trial is to evaluate the efficacy of PRF with 1% MF in treatment of mandibular class II furcation defects and its comparison to PRF and access therapy alone. Methods: This randomized trial was conducted on 75 patients with mandibular class II furcation defects. Defects were surgically treated with either access therapy alone (Group 1), access therapy+PRF (Group 2), and access therapy+ PRF+1% MF (Group 3). Clinical parameters like probing depth (PD), relative clinical attachment level {vertical (RVCAL) and horizontal (RHCAL)}, modified sulcus bleeding index (mSBI) and site specific plaque index (PI) were evaluated at baseline and 9 months post-operatively. Radiological assessment of bone defect fill was done at baseline and 9 months.

Conditions

Interventions

TypeNameDescription
PROCEDUREOpen flap debridement (OFD)Open flap debridement (OFD) alone
PROCEDUREOFD with Platelet rich fibrin (PRF)Open flap debridement (OFD) with Platelet rich fibrin (PRF) placement
PROCEDUREOFD with Platelet rich fibrin (PRF)+1% Metformin (Drug) in gel formOpen flap debridement (OFD) with Platelet rich fibrin (PRF)+1.2% Atorvastatin gel placement

Timeline

Start date
2015-09-01
Primary completion
2016-05-01
Completion
2016-05-01
First posted
2017-07-05
Last updated
2017-07-05

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT03207698. Inclusion in this directory is not an endorsement.

PRF+1% MF for Class II Mandibular Furcation Defects (NCT03207698) · Clinical Trials Directory